Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H H van der Zee

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Dermatology (Basel, Switzerland)|May 29, 2013
Failure of anti-interleukin-1 therapy in severe hidradenitis suppurativa: a case reportH H van der Zee, E P Prens
Dermatology (Basel, Switzerland)|October 15, 2011
The anti-inflammatory drug colchicine lacks efficacy in hidradenitis suppurativaH H van der Zee, E P Prens
Nederlands Tijdschrift Voor Geneeskunde|May 3, 2007
[Diagnostic image (319). A man with multiple yellow nodules]H H van der Zee, M R van de Scheur
Journal of the European Academy of Dermatology and Venereology : JEADV|October 21, 2019
Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trialsH H van der Zee, M Longcore, Z Geng, et al.
Dermatology (Basel, Switzerland)|August 22, 2012
Can animal skin diseases or current transgenic mice serve as a model for hidradenitis suppurativa?H H van der Zee, J D Laman, E P Prens
Journal of the European Academy of Dermatology and Venereology : JEADV|December 22, 2017
Hidradenitis suppurativa treated with wide excision and second intention healing: a meaningful local cure rate after 253 proceduresI E Deckers, Y Dahi, H H van der Zee, et al.
European Journal of Pharmacology|September 21, 2011
Pathogenesis and pharmacotherapy of Hidradenitis suppurativaMaiwand Nazary, H H van der Zee, E P Prens, et al.
The British Journal of Dermatology|August 18, 2009
Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot studyH H van der Zee, C J van der Woude, E F Florencia, et al.
JAMA Dermatology|October 14, 2020
Contribution of Genetics to the Susceptibility to Hidradenitis Suppurativa in a Large, Cross-sectional Dutch Twin CohortKelsey R van Straalen, Errol P Prens, Gonneke Willemsen, et al.
The British Journal of Dermatology|October 22, 2011
Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo studyH H van der Zee, J D Laman, L de Ruiter, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Dermatology (Basel, Switzerland)|May 29, 2013
Failure of anti-interleukin-1 therapy in severe hidradenitis suppurativa: a case reportH H van der Zee, E P Prens
Dermatology (Basel, Switzerland)|October 15, 2011
The anti-inflammatory drug colchicine lacks efficacy in hidradenitis suppurativaH H van der Zee, E P Prens
Nederlands Tijdschrift Voor Geneeskunde|May 3, 2007
[Diagnostic image (319). A man with multiple yellow nodules]H H van der Zee, M R van de Scheur
Journal of the European Academy of Dermatology and Venereology : JEADV|October 21, 2019
Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trialsH H van der Zee, M Longcore, Z Geng, et al.
Dermatology (Basel, Switzerland)|August 22, 2012
Can animal skin diseases or current transgenic mice serve as a model for hidradenitis suppurativa?H H van der Zee, J D Laman, E P Prens
Journal of the European Academy of Dermatology and Venereology : JEADV|December 22, 2017
Hidradenitis suppurativa treated with wide excision and second intention healing: a meaningful local cure rate after 253 proceduresI E Deckers, Y Dahi, H H van der Zee, et al.
European Journal of Pharmacology|September 21, 2011
Pathogenesis and pharmacotherapy of Hidradenitis suppurativaMaiwand Nazary, H H van der Zee, E P Prens, et al.
The British Journal of Dermatology|August 18, 2009
Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot studyH H van der Zee, C J van der Woude, E F Florencia, et al.
JAMA Dermatology|October 14, 2020
Contribution of Genetics to the Susceptibility to Hidradenitis Suppurativa in a Large, Cross-sectional Dutch Twin CohortKelsey R van Straalen, Errol P Prens, Gonneke Willemsen, et al.
The British Journal of Dermatology|October 22, 2011
Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo studyH H van der Zee, J D Laman, L de Ruiter, et al.
Pageof 3